NCT04366466

Brief Summary

In France, the number of emergency visits for suicide attempts is estimated at 220,000 per year. Suicide management aims to reduce suicide risk factors in order to improve the mental health of patients and prevent recurrences. To day, no study has compared the approaches to health surveillance and case management in a clinical trial, nor established the benefit of each on commitment to care and beyond the prevention of suicidal recurrence.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
138

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 16, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 29, 2020

Completed
2 days until next milestone

Study Start

First participant enrolled

May 1, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

April 30, 2020

Status Verified

April 1, 2020

Enrollment Period

1.3 years

First QC Date

April 16, 2020

Last Update Submit

April 29, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Clinical Global Impression (CGI)

    rating scales are measures of symptom severity, treatment response and the efficacy of treatments in treatment studies of patients with mental disorders.

    Day 0

  • Suicide Intent Scale

    The Suicide Intent Scale (SIS) developed by A.T. BECK in 1974, is the only scale that focuses solely on the assessment of the suicide attempt that has just taken place.

    Day 0

  • Montgomery-Asberg depression rating scale

    This scale is widely used to measure the changes brought about by the treatment of depression. It assesses the severity of symptoms in a wide variety of areas such as mood, sleep and appetite, physical and mental fatigue, and thoughts of suicide.

    Day 0

Secondary Outcomes (3)

  • Evaluating the effectiveness of the P.E.P.S. program in preventing suicidal recidivism

    1 year

  • Evaluate the level of possible generalization of the program

    1 year

  • Evaluate the feasibility of the program

    1 year

Study Arms (2)

suicide attempt patient who will receive sanitory supervision

OTHER

The control group will establish the health monitoring

Other: suicide attempt patient using PEPS Program

Suicide attempt patient who will participate to PEPS Program

EXPERIMENTAL

The intervention group will test the program of Promotion of Commitment to Care for the Prevention of Suicidal Recidivism.

Other: suicide attempt patient using PEPS Program

Interventions

The research protocol consists of two phases separated by randomization. A Hospital Phase common to both groups: Day zero is the day of the suicide attempt for which the patient came to the hospital. A post-hospital phase including the P.E.P.S. program for the intervention group and telephone reminders for the usual treatment group.

Also known as: Suicide attempt patient using sanitary supervision
Suicide attempt patient who will participate to PEPS Programsuicide attempt patient who will receive sanitory supervision

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18.
  • Male and female.
  • Admission to CH St Denis for a suicide attempt.
  • Referral for outpatient follow-up.
  • Patient with no psychiatric follow-up or who has been out of follow-up for at least three months.
  • Patient having given their written informed consent.

You may not qualify if:

  • Patients not affiliated with social security or state medical aid.
  • Patients who do not have the required faculties to be evaluated (cognitive and delusional disorders).
  • Patients treated for more than 72 hours after their procedure (maximum length of stay in the UAS and/or in medical intensive care.
  • Patient currently under psychiatric care.
  • Patients who cannot be called back by telephone (no telephone, homeless, incarceration).
  • Patients who do not master the French language.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2.

MeSH Terms

Conditions

SuicidePatient Acceptance of Health Care

Condition Hierarchy (Ancestors)

Self-Injurious BehaviorBehavioral SymptomsBehaviorTreatment Adherence and ComplianceHealth Behavior

Study Officials

  • Fayçal MOUAFFAK

    Investigateur Principal

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Youcef BENCHERIF

CONTACT

Rusheenthira THAVASEELAN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Controlled, randomized and prospective study of a cohort of suicide victims comparing an experimental (interventional) group to a control group (usual treatment)
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head of clinical research unit

Study Record Dates

First Submitted

April 16, 2020

First Posted

April 29, 2020

Study Start

May 1, 2020

Primary Completion

August 1, 2021

Study Completion

September 1, 2021

Last Updated

April 30, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share